Skip to content
healthcare.dev

Everolimus

NDC 70377-090, Everolimus, tablet, for suspension, from Biocon Pharma Inc..

Product NDC
70377-090
Status
Listed
Labeler
Biocon Pharma Inc.
Dosage form
TABLET, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA217216
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70377-090 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EVEROLIMUS2 mg/1

Pharmacologic classes

Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Immunologic Activity [PE]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]; mTOR Inhibitor Immunosuppressant [EPC]; mTOR Inhibitors [MoA]

Package NDCNDC-11Package
70377-090-117037700901128 TABLET, FOR SUSPENSION in 1 BOTTLE (70377-090-11)
70377-090-23703770090234 BLISTER PACK in 1 CARTON (70377-090-23) / 7 TABLET, FOR SUSPENSION in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5b809dfe-c076-07c5-207e-178c3f0d32d3

Use it

Look up 70377-090 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70377-090 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70377-090. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.